Dianthus Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Dianthus Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Dianthus Therapeutics Inc
Rating: 1.71541675
Author: Trendlyne DVM scores

about

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next...

25.21 0.97 (4.00%)

88.70% Gain from 52W Low

76,828

XNAS Volume

XNAS 28 Aug, 2025 10:34 AM (EDT)

Not Eligible

Expensive Valuation

10.2 / 100

Technically Neutral

58.5 / 100

1Yr Price target upside is 108%

11 analysts

Dianthus Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Dianthus Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next...

88.70% Gain from 52W Low

SWOT Analysis

Dianthus Therapeutics Inc Live Price Chart